 | Rocket Pharma begins patient dosing in early-stage RP-A501 trial
seekingalpha.com - June 18 at 5:29 PM |
 | Rocket Pharmaceuticals Inc (NASDAQ:RCKT) Given Average Recommendation of "Buy" by Analysts
www.americanbankingnews.com - June 14 at 8:51 AM |
| -$0.49 Earnings Per Share Expected for Rocket Pharmaceuticals Inc (NASDAQ:RCKT) This Quarter
www.americanbankingnews.com - June 9 at 12:21 AM |
 | Rocket Pharmaceuticals Sponsors 3rd Annual PKD Patients’ Forum
finance.yahoo.com - June 6 at 6:01 PM |
| Did You Manage To Avoid Rocket Pharmaceuticals's (NASDAQ:RCKT) 19% Share Price Drop?
finance.yahoo.com - May 23 at 6:37 PM |
| Did You Manage To Avoid Rocket Pharmaceuticals's (NASDAQ:RCKT) 19% Share Price Drop?
finance.yahoo.com - May 23 at 6:37 PM |
| Here’s What Hedge Funds Think About Rocket Pharmaceuticals, Inc. (RCKT)
finance.yahoo.com - May 9 at 6:44 PM |
| Rocket Pharmaceuticals Announces Participation at the Bank of America Merrill Lynch 2019 Healthcare Conference
finance.yahoo.com - May 7 at 9:19 AM |
| Rocket Pharmaceuticals Presents Preclinical Data of RP-A501 for Danon Disease at the American Society of Gene and Cell Therapy 2019 Annual Meeting
finance.yahoo.com - May 2 at 9:26 AM |
| Rocket Pharma nabs $6.5M grant to support gene therapy development
seekingalpha.com - April 30 at 6:06 PM |
| Rocket Pharmaceuticals Receives Funding from the California Institute for Regenerative Medicine (CIRM)
finance.yahoo.com - April 30 at 9:15 AM |
| Rocket prices stock offering at $17.50
seekingalpha.com - April 16 at 9:52 AM |
| Rocket Pharma prices stock offering at $17.50
seekingalpha.com - April 16 at 9:52 AM |
 | 10 Stocks To Watch For April 16, 2019
feeds.benzinga.com - April 16 at 5:52 AM |
| Rocket Pharmaceuticals Announces Upcoming Presentations at the American Society of Gene and Cell Therapy 2019 Annual Meeting
finance.yahoo.com - April 15 at 6:28 PM |
 | Noteworthy Thursday Option Activity: RCKT, TWLO, AWR
www.nasdaq.com - March 21 at 6:34 PM |
| First Week of May 17th Options Trading For Rocket Pharmaceuticals
www.nasdaq.com - March 21 at 6:34 PM |
 | Rocket Pharmaceuticals Inc
www.bloomberg.com - March 19 at 9:40 AM |
| Rocket Pharma up 8% ahead of presentations at ACC
seekingalpha.com - March 15 at 6:30 PM |
| Rocket Pharmaceuticals Announces Presentations at the American College of Cardiology 2019 Annual Meeting
finance.yahoo.com - March 15 at 9:42 AM |
 | Rocket Pharmaceuticals Sponsors Clinical Trial at University of California, Los Angeles (UCLA) - Business Wire
www.businesswire.com - March 13 at 6:14 PM |
| Rocket Pharmaceuticals Announces First Patient Dosed in Phase 1 Clinical Trial of RP-L102 in the U.S. - Business Wire
www.businesswire.com - March 13 at 6:14 PM |
| Dosing underway in Rocket Pharma early-stage study of RP-L102 in rare anemia
seekingalpha.com - March 12 at 10:21 AM |
| Rocket Pharmaceuticals Announces First Patient Dosed in Phase 1 Clinical Trial of RP-L102 in the U.S.
finance.yahoo.com - March 12 at 10:21 AM |
| Are Insiders Selling Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT) Stock?
finance.yahoo.com - March 12 at 10:21 AM |
| Rocket Pharma sponsors clinical trial for LAD-I and IMO
seekingalpha.com - March 11 at 11:10 AM |
| Rocket Pharmaceuticals Sponsors Clinical Trial at University of California, Los Angeles (UCLA)
finance.yahoo.com - March 11 at 11:10 AM |
| Rocket Pharmaceuticals Reports Full Year 2018 Financial Results and Operational Highlights
finance.yahoo.com - March 7 at 9:51 AM |
| Rocket Pharmaceuticals Announces Participation at Upcoming Conferences - Business Wire
www.businesswire.com - March 5 at 5:59 PM |
| Rocket Pharmaceuticals Recognizes Rare Disease Day® 2019
finance.yahoo.com - February 28 at 9:27 AM |
| Rocket Pharmaceuticals Announces Publication of Comprehensive Review of Danon Disease Cases in the International Journal of Cardiology - Business Wire
www.businesswire.com - February 26 at 9:47 AM |
| Rocket Pharmaceuticals Announces Publication of Comprehensive Review of Danon Disease Cases in the International Journal of Cardiology
finance.yahoo.com - February 26 at 9:47 AM |
| Rocket Pharmaceuticals Announces Participation in Fireside Chat at the 8th Annual SVB Leerink Global Healthcare Conference
finance.yahoo.com - February 20 at 9:36 AM |
| FDA clears Rocket Pharma's IND for RP-A501
seekingalpha.com - January 22 at 9:24 AM |
| Rocket Pharmaceuticals Announces Clearance of IND for RP-A501 Gene Therapy for Danon Disease
finance.yahoo.com - January 22 at 9:24 AM |
 | Form 8-K ROCKET PHARMACEUTICALS, For: Dec 27 - StreetInsider.com
www.streetinsider.com - December 29 at 9:18 AM |
| Rocket Pharmaceuticals to join NBI - Seeking Alpha
seekingalpha.com - December 22 at 4:40 PM |
| Rocket Pharmaceuticals to Join NASDAQ Biotechnology Index
finance.yahoo.com - December 21 at 9:13 AM |
| Rocket Pharmaceuticals Announces Closing of Public Offering and Full Exercise of the Underwriters' Option to Purchase Additional Shares - Business Wire
www.businesswire.com - December 1 at 9:33 AM |
| Rocket Pharma closes $63M capital raise
seekingalpha.com - November 30 at 4:47 PM |
| Rocket Pharmaceuticals Announces Closing of Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares
finance.yahoo.com - November 30 at 4:47 PM |
| Rocket Pharmaceuticals Receives FDA Regenerative Medicine Advanced Therapy (RMAT) and Fast Track Designations for RP-L102 Gene Therapy for Fanconi Anemia - Business Wire
www.businesswire.com - November 29 at 9:42 AM |
| RTW Investments Announces Private Placement Transaction with Rocket Pharmaceuticals, Inc. - Business Wire
www.businesswire.com - November 29 at 9:42 AM |
| Rocket Pharma prices stock offering at $15.50
seekingalpha.com - November 28 at 9:35 AM |
 | RTW Investments Announces Private Placement Transaction with Rocket Pharmaceuticals, Inc.
www.marketwatch.com - November 28 at 9:35 AM |
| Rocket Pharma nabs $15M in new capital in private transaction
seekingalpha.com - November 28 at 9:35 AM |
 | Rocket Pharma Grounded Despite Positive FDA Update
247wallst.com - November 27 at 4:33 PM |
| Rocket Pharmaceuticals receives RMAT and Fast Track designations for RP-L102
seekingalpha.com - November 27 at 9:47 AM |
| Rocket Pharma (RCKT) Announces Preclinical Data for AAV-Based RP-A501 to Treat Monogenic Heart Failure Syndrome
www.streetinsider.com - November 26 at 4:43 PM |
| Rocket Pharma up 8% on advancement of AAV gene therapy for Danon disease
seekingalpha.com - November 26 at 4:43 PM |
